Data & Reference

Peptide Research Glossary

For Research Use Only. Not for Human or Veterinary Use.

Overview

Plain-language, A-to-Z definitions — with worked context and cross-references — of the chemistry, manufacturing, pharmacology and target/pathway terms used across this database.

A

TermMeaning
AgonistA molecule that binds a receptor and switches it on, triggering the same downstream signalling as the receptor’s natural ligand. Most of the compounds in this database — the GLP-1 analogues, the GHSR/GHRH-targeting growth peptides — are studied as agonists rather than blockers. See also: GPCR, GHRH, GHS / GHSR-1a.
Amidation / acetylationTwo common end-capping modifications: amidation replaces the C-terminal -COOH with -CONH₂, and acetylation caps the N-terminal amine with an acetyl group. Both remove a charged, enzyme-recognisable terminus, which is one of the most reliable ways to slow proteolytic breakdown and extend a short peptide’s working half-life. Argireline and SNAP-8 in this database carry both modifications at once. See also: Proteolysis, Peptide bond.
Amino acidThe building block of peptides and proteins: a small organic molecule with an amino group (-NH₂), a carboxyl group (-COOH) and a side chain that gives it its identity. Twenty standard (proteinogenic) amino acids link together via peptide bonds to form the sequences catalogued in this database; several entries also use non-standard residues (D-amino acids, Aib, Dmt) for extra stability. See also: Peptide bond, D-amino acid, Sequence.

B

TermMeaning
Bacteriostatic waterSterile water with 0.9% benzyl alcohol added as a preservative, used to reconstitute lyophilized peptide powder for multi-dose research use. The benzyl alcohol suppresses bacterial growth so a vial can be accessed repeatedly over days to weeks, which plain sterile water (single-use only) cannot support. See also: Reconstitution, Lyophilized.
BioavailabilityThe fraction of an administered dose that reaches systemic circulation intact and available to act. It is shaped by route of administration, molecular size, lipophilicity and how quickly the compound is broken down in transit — subcutaneous injection typically gives much higher bioavailability than the oral route for an unmodified peptide. See also: Half-life (t½), SC (subcutaneous), Proteolysis.

C

TermMeaning
CardiolipinA phospholipid unique to the inner mitochondrial membrane, essential for the membrane curvature and protein complexes that keep oxidative phosphorylation running normally. SS-31 (Elamipretide) is studied specifically for binding and stabilising cardiolipin under oxidative stress, which distinguishes its mechanism from the other mitochondrial peptides in this database. See also: MDP.
CAS numberA unique numeric identifier (format XXX-XX-X) assigned by the Chemical Abstracts Service to every distinct chemical substance described in the scientific literature. It lets a compound be identified precisely across suppliers, databases and regulatory paperwork regardless of which trade or research name is used for it — every profile page in this database lists its compound’s CAS number.
COACertificate of Analysis — the per-batch quality document accompanying a research-peptide order, reporting HPLC purity, mass-spec (LC-MS/ESI-MS) identity confirmation and, where relevant, trace-element results such as ICP-MS copper content for GHK-Cu. See also: HPLC, LC-MS / ESI-MS, Purity (≥ 98%).

D

TermMeaning
D-amino acidThe mirror-image (stereoisomeric) form of a standard L-amino acid. Substituting one or more D-residues into a sequence — as in Ipamorelin, the GHRPs and SS-31 — is a common design strategy because proteolytic enzymes are stereospecific and often cannot cleave a D-residue-containing bond, extending the peptide’s working half-life. See also: Proteolysis, Amino acid.
DACDrug-Affinity-Complex technology: a chemical handle (typically a maleimide group) that binds covalently to circulating serum albumin once injected. Conjugating a short-acting peptide to DAC — as with CJC-1295 — turns a molecule with a half-life of minutes into one that circulates for several days, because it now rides along with albumin’s own long circulating lifetime. See also: Half-life (t½).
DeamidationA slow, non-enzymatic breakdown pathway in which the side-chain amide of an asparagine (Asn) or glutamine (Gln) residue hydrolyses to a free acid, converting Asn→Asp or Gln→Glu. It is a recognised degradation route for peptides in solution and one of the reasons reconstituted material is time- and temperature-limited. See also: Reconstitution, Proteolysis.
Disulfide bondA covalent -S-S- link formed between the thiol groups of two cysteine residues, which locks part of a peptide into a fixed three-dimensional shape. AOD-9604 and Humanin in this database each carry cysteine residues capable of forming such a bridge; most of the shorter research peptides here have no cysteines and so no disulfide chemistry to consider. See also: Amino acid.

E

TermMeaning
ESI-MSElectrospray-ionization mass spectrometry — an ionization technique that sprays a peptide solution through a charged capillary to produce multiply charged gas-phase ions for mass analysis. Because it produces several charge states ((M+H)⁺, (M+2H)²⁺, and so on) rather than one, it is well suited to confirming the identity of the larger, multiply-charged peptides in this database. See also: LC-MS / ESI-MS, Molecular weight (MW).

F

TermMeaning
Fmoc/tBuThe dominant protecting-group strategy in modern solid-phase peptide synthesis: Fmoc (fluorenylmethyloxycarbonyl) temporarily blocks the amino terminus during each coupling step, while tBu (tert-butyl) groups protect reactive side chains, both removed at the end of synthesis. It replaced the older, harsher Boc/Bzl chemistry for most research-scale peptide manufacturing. See also: SPPS.

G

TermMeaning
GHRHGrowth-hormone-releasing hormone — the 44-residue hypothalamic hormone whose active core, GHRH(1–29), is the template for the GHRH-analogue peptides in this database. Binding its receptor (GHRH-R) on pituitary somatotrophs drives Gαs/cAMP signalling and pulsatile growth-hormone release; Sermorelin and CJC-1295 are both engineered GHRH(1–29) analogues. See also: GHS / GHSR-1a, DAC.
GHRPGrowth-hormone-releasing peptide — a class of small synthetic peptides (GHRP-2, GHRP-6 and related analogues such as Ipamorelin) that activate the ghrelin receptor (GHSR-1a) to stimulate growth-hormone release, acting through a pathway distinct from and complementary to GHRH. See also: GHS / GHSR-1a, GHRH.
GHS / GHSR-1aGrowth-hormone secretagogue, and the receptor (GHSR-1a, the ghrelin receptor) that secretagogues act on. Ghrelin-mimetic compounds in this database — MK-677, Ipamorelin, GHRP-2 and GHRP-6 — activate this receptor to stimulate pulsatile GH release independently of the GHRH pathway. See also: GHRH, Agonist.
GLP-1 / GIP / GCGRThree related metabolic receptors targeted by the GLP-1-class peptides in this database. GLP-1 and GIP are incretin receptors that boost insulin release after eating; GCGR is the glucagon receptor, whose activation raises energy expenditure. Tirzepatide is a GIP/GLP-1 dual agonist and Retatrutide additionally activates GCGR, adding the energy-expenditure effect on top of the incretin actions. See also: Incretin, GPCR.
GPCRG-protein-coupled receptor — the largest family of cell-surface signalling receptors, and the target class for most of the compounds in this database (GHSR-1a, GHRH-R, GLP-1/GIP/GCGR). Ligand binding triggers an intracellular G-protein cascade (commonly Gαs → adenylyl cyclase → cAMP) that carries the signal into the cell. See also: Agonist.

H

TermMeaning
Half-life (t½)The time needed for a compound’s concentration in circulation to fall by half. It is shortened by rapid proteolytic cleavage or renal clearance and can be deliberately extended by modifications such as amidation, D-amino-acid substitution, or — for the largest effect — DAC/albumin binding or fatty-acid acylation, which is why CJC-1295 (with DAC) circulates for days while unmodified GHRP-class peptides last only minutes. See also: Proteolysis, DAC, Bioavailability.
HPLCHigh-performance liquid chromatography — the standard analytical method for separating, identifying and quantifying a peptide’s purity. Reversed-phase HPLC on a C18 column with UV detection (typically 214 nm) is the industry-standard configuration; the ≥ 98% purity figure quoted throughout this database is an HPLC peak-area result. See also: Purity (≥ 98%), LC-MS / ESI-MS.

I

TermMeaning
ICP-MSInductively-coupled-plasma mass spectrometry — a trace-element analytical technique used where a compound’s identity depends on a bound metal, most notably confirming copper content in GHK-Cu batches. See also: COA.
IGF-1Insulin-like growth factor 1 — released from the liver downstream of growth-hormone signalling, and the most common secondary research endpoint (alongside GH itself) used to evaluate the GHRH- and GHSR-targeting peptides in the Growth Factors & Signaling category.
INCI nameInternational Nomenclature of Cosmetic Ingredients — the standardized ingredient name that must appear on a cosmetic product’s label. It is distinct from the compound’s CAS number or research name; GHK-Cu, for example, is listed on cosmetic labels as “Copper Tripeptide-1”. See also: CAS number.
IncretinGut-derived hormones — chiefly GLP-1 and GIP — released after eating that amplify glucose-stimulated insulin secretion. The GLP-1-class research peptides in this database are incretin-receptor agonists engineered for a much longer duration of action than the natural, minutes-long incretin hormones. See also: GLP-1 / GIP / GCGR.

K

TermMeaning
Karl FischerA coulometric or volumetric titration method for measuring residual water content in a lyophilized powder. Excess residual moisture accelerates hydrolytic degradation pathways such as deamidation, so it is a standard release-testing parameter alongside HPLC purity. See also: Deamidation, Lyophilized.

L

TermMeaning
LC-MS / ESI-MSLiquid chromatography coupled to mass spectrometry — most often using electrospray ionization (ESI) — run alongside HPLC to confirm not just purity but molecular identity, by matching the observed mass (or multiply-charged m/z values) against the compound’s expected molecular weight. See also: ESI-MS, Molecular weight (MW).
Lipophilicity (logP)The base-10 logarithm of a compound’s octanol/water partition coefficient — a measure of its preference for a lipid versus an aqueous environment. Negative logP values (most short peptides in this database) indicate a hydrophilic compound; positive values (e.g. Matrixyl, palmitoylated for skin penetration) indicate a lipophilic one. logP influences membrane permeability, formulation behaviour and tissue distribution. See also: Bioavailability.
LyophilizedFreeze-dried: a frozen peptide solution is dried under vacuum so the ice sublimes directly to vapour, leaving a stable, low-moisture powder. This is the standard shipping and storage form for essentially every peptide in this database, chosen because it is far more stable long-term than a liquid solution. See also: Reconstitution, Bacteriostatic water.

M

TermMeaning
MatrikineA small bioactive fragment released from an extracellular-matrix protein (e.g. collagen) that signals surrounding cells to remodel or rebuild tissue, rather than simply providing structure itself. GHK-Cu and the Matrixyl family are matrikine-class cosmetic peptides studied for exactly this signalling activity in dermal-fibroblast research. See also: Peptide bond.
MDPMitochondrial-derived peptide — a short peptide encoded within mitochondrial DNA (rather than the nuclear genome) and processed from a normally non-coding or alternative reading frame. MOTS-c and Humanin, both in the Mitochondrial & Metabolic category, are the two best-characterised examples. See also: Cardiolipin.
Molecular weight (MW)The mass of one molecule of a compound, expressed in daltons (Da) or g/mol — reported here as average mass (weighted by natural isotope abundance). MW is the primary parameter for confirming compound identity by mass spectrometry and for converting a research dose between mass and molar units. See also: ESI-MS, Lipophilicity (logP).

N

TermMeaning
NootropicA compound studied for effects on cognition — learning, memory, attention or neuroprotection — without primarily acting as a sedative or stimulant. Semax, Selank and Noopept in the Cognitive & Neuro Regulation category are all studied in this context, generally through neurotrophic (BDNF/TrkB-linked) or neuromodulatory pathways rather than classic receptor agonism.

P

TermMeaning
PeptideA short chain of amino acids joined by peptide bonds. There is no strict cutoff, but peptides are conventionally distinguished from proteins by chain length — most entries in this database run from 3 to about 40 residues, well within the peptide range; a few non-peptide small molecules (MK-677, Noopept) and one biological mixture (Cerebrolysin) are included for research completeness and are labelled as such. See also: Peptide bond, Amino acid.
Peptide bondThe covalent amide bond (-CO-NH-) formed between the carboxyl group of one amino acid and the amino group of the next during synthesis, releasing a water molecule. A chain of these bonds forms a peptide’s backbone and gives it partial double-bond rigidity along its length. See also: Amino acid, SPPS.
pI (isoelectric point)The pH at which a peptide’s ionizable groups — its N- and C-termini plus any Asp, Glu, Arg, Lys or His side chains — balance out to zero net charge. A peptide is least soluble and most prone to aggregation near its own pI, so formulation and storage buffers are generally chosen to stay well away from it. See also: Amino acid, Lipophilicity (logP).
ProteolysisThe enzymatic cleavage of peptide bonds by proteases and peptidases — the dominant degradation pathway for peptides once in circulation, and the main factor limiting half-life. Resistance is engineered through D-amino-acid substitution, amidation/acetylation, cyclization or backbone modification. See also: Half-life (t½), D-amino acid, Amidation / acetylation.
Purity (≥ 98%)The proportion of the target compound within a batch, measured as HPLC peak area rather than by weight. ≥ 98% is the typical release threshold quoted across this database for research-grade peptides (small molecules such as Noopept are held to ≥ 99%); the remaining fraction is process-related impurities and residual TFA/solvent. See also: HPLC, TFA, COA.

R

TermMeaning
ReconstitutionDissolving a lyophilized peptide powder in a suitable diluent — typically bacteriostatic water — to prepare a working solution. Slow addition down the vial wall, gentle swirling rather than shaking, and aseptic technique all reduce the risk of denaturation, aggregation or contamination during this step. See also: Bacteriostatic water, Lyophilized.

S

TermMeaning
SC (subcutaneous)Injection into the subcutaneous fat layer just beneath the skin — the most common administration route used in research protocols for the injectable peptides in this database, chosen for its combination of good bioavailability (roughly 60–90% for most peptides) and technical simplicity relative to IV dosing. See also: Bioavailability.
SequenceThe ordered list of amino acids making up a peptide, written in one-letter (e.g. GHK) or three-letter (Gly-His-Lys) code, together with any terminus capping or non-standard residues. Every entry in the Sequence Database on this site is checked against that compound’s own profile page. See also: Amino acid, Peptide bond.
SPPSSolid-phase peptide synthesis — the standard method for chemically assembling a peptide, one residue at a time, on an insoluble resin support, with each amino acid’s reactive groups temporarily protected until its turn to couple. Modern SPPS almost always uses Fmoc/tBu protecting-group chemistry and can reliably build peptides up to roughly 30–50 residues. See also: Fmoc/tBu, Peptide bond.

T

TermMeaning
TelomeraseThe ribonucleoprotein enzyme that extends the repetitive TTAGGG sequence at chromosome ends (telomeres), counteracting the shortening that otherwise occurs with each cell division. Epitalon is studied specifically for its reported ability to upregulate telomerase activity in somatic cells, which is the basis for its placement in the Sleep & Pineal Peptides category alongside Pinealon.
TFATrifluoroacetic acid — a strong organic acid used both as an ion-pairing agent in HPLC purification and as the standard cleavage/side-chain-deprotection reagent in SPPS. Trace TFA (commonly 1–10% by weight, bound as a counter-ion to basic residues) can remain in the final peptide salt and is a recognised, generally accounted-for component of research-peptide purity specifications. See also: HPLC, SPPS, Purity (≥ 98%).
TrkB receptorThe high-affinity receptor for BDNF (brain-derived neurotrophic factor), activating downstream MAPK/ERK, PI3K/Akt and PLCγ signalling linked to neuronal growth and plasticity. Semax and Noopept are both studied for neurotrophic effects proposed to act at least partly through this pathway. See also: Nootropic.

Need research-grade peptides?

HPLC-verified, COA per batch. Tell us the quantity you need.

Request a Quote